Influenza Diagnostics Market are Showing Strong Growth Dynamics

 

Influenza Diagnostics Market

Global Influenza Diagnostics Market Driven By Increase Disease Awareness

According to the analysis of Market Research Future (MRFR), the global influenza diagnostics market is anticipated to register a moderate CAGR of 7.80% to acquire a USD 954.512 million by 2023.

Influenza is a transmittable respiratory infection triggered by several flu viruses. Pandemics influenza is noted as a new flu virus strain that can quickly spread from person to person. Every year recurrent flu affects millions of people and results in thousands of hospitalizations and flu-related deaths. Growing geriatric patient population, the introduction of quadrivalent influenza vaccines, and growing disease awareness drive the growth of the global influenza diagnostics market. However, stringent regulations may hinder the growth of the market over the evaluation period.

Get Sample Report: https://www.marketresearchfuture.com/sample_request/3142

Key Players

The key players identified in the global influenza diagnostics market are Abbott, Analytik Jena AG, Becton, Biocartis, Cepheid, bioMérieux Inc, DiaSorin S.p.A., Dickinson and Company, GenMark Diagnostics, Inc., Luminex Corporation, F. Hoffmann-La Roche Ltd, Meridian Bioscience, Inc., SA Scientific, Quidel Corporation, Thermo Fisher Scientific Inc.

Segmental Analysis

The global market for influenza diagnostics is segmented based on type, tests, and end-users.

·         The types of influenza infections in the market are type A flu, Type B flu, and type C flu. The type-A flu segment is anticipated to lead the market and record a considerable CAGR to acquire USD 954.512 million by the end of the evaluation period. These viruses were majorly responsible for large annual epidemics in the past. Nevertheless, the type B flu segment is anticipated to exhibit the highest CAGR of 8.66% over the assessment period. The increase in government initiatives to reduce the prevalence of influenza, increasing awareness among consumers and the augmented risk of contracting influenza are anticipated to drive market growth over the forecast period.

·         The various kinds of tests available for the diagnosis of influenza are traditional diagnostic tests and molecular diagnostic tests.

·         Based on end-users, the influenza diagnostics market has been segmented into hospitals and clinical laboratories, and point of care testing.

Regional Analysis

Based on the region, the global influenza diagnostics market is analyzed in the Americas, Europe, asia Pacific, and the middle east and Africa.

The Americas (North America and Latin America) account for the largest market share and are likely to retain their lead over the forecast period. The market growth in this region is primarily attributed to the growing prevalence of influenza among the geriatric population, and the availability of advanced healthcare facilities in this region.

The European market for influenza diagnostics is anticipated to be the second-largest during the review period. The growing number of pharmaceutical companies exporting their products abroad or within Europe is projected to contribute to market growth. The factors accountable for the market growth in this region are an increase in disease awareness among consumers, initiatives taken by governmental and advisory bodies to ensure vaccination procedures against influenza, and a surge in the size of the aging population. The influenza diagnostics market in Europe is predicted to be impacted by several other factors the review period, such as the numerous favorable factors such as the introduction of innovative technologies, affordable pricing, reimbursement, unmet medical necessities in certain regions, and strong clinical pipeline.

Asia-Pacific is assessed to be the fastest growing market owing to the developing healthcare infrastructure. Due to the growing prevalence of other diseases such as cardiovascular, endocrinology, lymphatic systems, and respiratory disorders, the market growth for influenza diagnostics is expected to rise over the evaluation period. The increasing efforts taken by the governments to increase consumer awareness, provide suitable vaccines, and fulfill the unmet needs in certain countries, is substantially driving the market growth over the assessment period.

The Middle East and Africa region (MEA) are expected to acquire the smallest market share in the forecast period, owing to the weak healthcare sector in certain parts of Africa. The Middle East is likely to contribute to the majority of the market share registers from this region.

Browse Full Reports: https://www.marketresearchfuture.com/reports/influenza-diagnostics-market-3142

 

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

Comments

Post a Comment

Popular posts from this blog

Dry Age-Related Macular Degeneration Market Size, Share, Application Analysis, Regional Outlook, Growth Trends, Competitive Strategies

Image
  Dry Age-Related Macular Degeneration Market This degenerative eye disease is caused by the thinning of the macula and interferes with a clear vision in the elderly. The macula is part of the retina that facilitates clear vision; when this part of the eye deteriorates, it causes blurred or distorted vision. But this does not mean that the individual will lose his or her sight, only the central vision is affected by this degenerative disease, and the peripheral vision remains intact. Vision loss is slow and can be corrected using innovative ocular treatments. It has been estimated that the Dry Age-Related Macular Degeneration Market has seen a jump due to increased research in drugs, rising amount of COVID-19 cases among the old and age-restricted chronic diseases.   The dry age-related macular degeneration AMD market is expected to cross USD 15,351.07 million by 2027 at a CAGR of 8.20% during the forecast period   List of Key Companies Covered...
Read more

Cardiopulmonary Resuscitation Market: Innovations and Trends Shaping Life-Saving Techniques

  Introduction Cardiopulmonary Resuscitation (CPR) stands as a vital life-saving technique that has transformed emergency healthcare. As the cornerstone of effective response to cardiac arrest, the CPR market has been witnessing remarkable advancements driven by technology, research, and innovation. This article delves into the evolving landscape of the Cardiopulmonary Resuscitation Market, highlighting its trends, innovations, and impact on global healthcare. CPR: A Lifeline in Critical Moments Cardiopulmonary resuscitation, commonly referred to as CPR, is a crucial technique employed to sustain blood circulation and provide oxygen to the brain during cardiac arrest. It involves chest compressions and, in some cases, rescue breaths to maintain oxygen levels until professional medical assistance arrives. CPR significantly increases the chances of survival when performed promptly and correctly. Market Growth and Trends The CPR market has been experiencing steady growth due to incre...
Read more

Pain Management Devices Market Set To Exhibit Strong Growth, Valuable Research Factors and Industry Forecast to 2030

Image
  Pain Management Devices Market – Overview The Pain Management Devices Market can anticipate expansion at a rate of 7.12% from 2020 to 2030, believes MRFR (Market Research Future). Progress in technology and better research capabilities have led to the development of devices that can control pain with limited use of drugs. Focused Market reports connected to the healthcare sector among others lately have been made available by Market Research Future which publishes a report on this sector. The development of pain management devices has been useful to control pain in a wide range of ailments. The level of relief from pain that is experienced, is one of the major driving factors for the industry, as patients who use such devices are prone to chronic pain daily. Cancer patients and the geriatric population are among the major user segments for the pain management devices as medication alone may not be sufficient to provide pain relief in their situation. The industry is antici...
Read more